Researchers have shown that inhibiting a key metabolic enzyme selectively kills melanoma cells and stops tumor growth. The findings could lead to a new class of drugs to selectively treat melanoma, the most severe form of skin cancer.
Inhibiting key metabolic enzyme shows promise against melanoma
